Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced its fourth quarter and full-year 2024 financial results, along with key pipeline advancements and corporate updates signaling a pivotal year ahead.
Aclaris Reports 2024 Financial Results and Sets Stage for Transformative 2025 Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that its President and CEO, Jayson Rieger, PhD, MBA, will participate in a fireside chat at the TD Cowen 45th …
Verrica Pharmaceuticals CEO to Speak at TD Cowen 45th Annual Health Care Conference Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has announced that its management team will deliver a presentation at the TD Cowen 45th Annual Healthcare Conference. The presentation is scheduled …
Palvella Therapeutics to Present at TD Cowen 45th Annual Healthcare Conference Read More
WEST CHESTER, PA — Qurate Retail, Inc. (Nasdaq: QRTEA, QRTEB, QRTEP) has announced a major rebranding, officially becoming QVC Group, Inc. The name change highlights the company’s evolution and commitment …
Qurate Retail Rebrands as QVC Group to Drive Live Social Shopping Growth Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced that its Compensation Committee recently approved inducement grants of restricted stock units (RSUs) covering 7,200 shares of common stock. These grants, …
TELA Bio Announces Inducement Grants to Newly Hired Employees Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) shared new and updated results from its RESET clinical development program at major scientific conferences, presenting data on the first 10 patients treated …
Cabaletta Bio Reveals Promising Clinical Data for Autoimmune Therapy Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced the successful completion of a full study on its localized pain management product, Probudur™, conducted in partnership with the U.S. Army …
Virpax Pharmaceuticals Advances Pain Management with Promising Probudur Study Results Read More
EXTON, PA — Innovative Solutions & Support, Inc. (Nasdaq: ISSC) posted robust fiscal first quarter results, reporting $16.0 million in revenue, a 71.6% increase compared to the prior year. The growth …
IS&S Reports Strong Fiscal Q1 2025 Results with 71.6% Revenue Growth Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced the completion of dosing in the Phase 2 portion of its ArMaDa clinical trial for OCU410. This novel multifunctional modifier gene therapy …
Breakthrough Gene Therapy OCU410 Could Save Millions from Vision Loss – Phase 2 Milestone Achieved! Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug that acts as a covalent inhibitor of two key immune signaling kinases, ITK …
Aclaris Therapeutics Unveils Promising Data on ATI-2138, a Novel Dual ITK/JAK3 Inhibitor Read More